로딩 중…
지수 로딩 중…
DongKook Pharmaceutical Co., Ltd.
086450· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩18,240-3.03%
2026-06-19
Price Chart
DongKook Pharmaceutical Co., Ltd.+7.11%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 825.00B KRW |
| Revenue | 954.16B KRW |
| Net Income | 75.88B KRW |
| Total Assets | 1.09T KRW |
| Net Assets | 780.60B KRW |
| Employees | 1,216 |
| Value | |
| P/E | 10.87x |
| P/B | 1.06x |
| PEG | 0.18x |
| P/S | 0.86x |
| EV/EBITDA | 31.70x |
| FCF Yield | 3.16% |
| Profitability | |
| ROE | 9.72% |
| ROA | 6.95% |
| Op. Margin | 10.33% |
| Revenue Growth | 12.19% |
| Earnings Growth | 59.92% |
| Financial Health | |
| Debt Ratio | 39.81% |
| Total Debt | 67.98B KRW |
| FCF | 26.05B KRW |
| Cash | 58.69B KRW |
| Current Ratio | 2.06x |
| Net Debt/EBITDA | 0.35x |
| Dividend | |
| Div. Yield | 1.06% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 7.11% |
| 1M Return | -12.52% |
| From 52W High | -41.63% |
| 1Y MDD | -44.68% |
| Trading | |
| Volume | 323,416 shares |
| Foreign Own. | 17.30% |
| Per Share | |
| EPS | 1,648 KRW |
| BPS | 15,058 KRW |
Company Info
Dongguk Pharmaceutical, established in 1968 and listed on KOSDAQ in 2007, is a pharmaceutical company with subsidiaries including Dongguk Pharmaceutical Life Science. It manufactures and sells over-the-counter drugs, prescription drugs, and active pharmaceutical ingredients, alongside supplying cosmetics, health functional foods, and household goods domestically and internationally. The company has built a strong production base through mass production of natural material ingredients, automated warehouses, and secure manufacturing spaces. It is expanding into a global pharmaceutical company by exporting new platform technology products overseas. The company is headquartered in Gangnam-gu, Seoul.